Vaccine

Business

Giant GSK Spends $3.3 Billion To Acquire Affinivax

GSK agreed to buy Affinivax for $3.3B in its biggest deal in 2 months, giving the British pharmaceutical giant access…

Read More »
News

Novavax Posts Q1 Profit After Introducing the Covid Vaccine

Novavax revealed Q1 following the introduction of the Covid-19 vaccine in several countries around the world, despite its failure to…

Read More »
News

The Giant Pfizer Trims 2022 Earnings Guidance

Pfizer trimmed its 2022 earnings guidance, despite reporting better-than-bottom-and-higher Q1 results thanks to better sales of its coronavirus vaccine

Read More »
News

Johnson & Johnson Cuts 2022 Forecast After 1Q Results

J&J has announced that it will cut its full-year sales and profit forecast and stop providing revenue guidance for its…

Read More »
News

Moderna and Pfizer Stocks Fall as the Omicron Wave Recedes

Shares of the major manufacturers of Covid vaccines fell after the unprecedented wave of the outbreak of infections with the…

Read More »
News

Moderna Lowers Sales Forecast For Covid Vaccine

Moderna's shares plunged 16% after failing to meet expectations in its third quarter and slashing its full-year COVID-19 vaccine sales…

Read More »
News

Pfizer Raises Sales Expectations of The Covid Vaccine

Pfizer announced that it raised full-year sales forecast for COVID-19 vaccine by 7.5% to $36B, coinciding with signing new contracts…

Read More »
News

Johnson & Johnson Vaccine Sales Fly Up in the Third Quarter

J&J revealed that sales of its vaccine reached $502 million during the third quarter in its quarterly results report, which…

Read More »
News

GSK is Optimistic About Earnings Growth, But Investor Concern Remains

GSK is forecasting that its 2021 earnings will reach the top of its guidance range, but mounting debt and the…

Read More »
Business

Eurozone business growth at fastest pace in 15 years

Business and enterprise growth in the EU accelerated, surpassing its highest value in 15 years, the impact of which was…

Read More »
Back to top button